Is the prevalence of visual impairment rising or falling in the peoplewith diabetesmellitus?: It depends on who you study

JAMA Ophthalmology

Volumn 131, Issue 7, 2013, Pages 948-950

  Klein, Ronald ^a   Klein, Barbara E K ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DIABETIC RETINOPATHY; FEMALE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POVERTY; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; VISUAL ACUITY; VISUAL IMPAIRMENT;

DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; VISION DISORDERS;

EID: 84880252249     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.4023     Document Type: Article

References (25)

1. Imperatore G, Boyle JP, Thompson TJ, et al; SEARCH for Diabetes in Youth Study Group. Projections of type 1 and type 2 diabetes burden in the U. S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care. 2012;35(12): 2515-2520.
2. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4-14.
3. Klein R, Klein BE. Are individuals with diabetes seeing better?: a long-term epidemiological perspective. Diabetes. 2010;59(8):1853-1860.
4. Klein R, Lee KE, Gangnon RE, Klein BE. The 25-year incidence of visual impairment in type 1 diabetes mellitus: theWisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology. 2010;117(1):63-70.
5. Klein R, Lee KE, KnudtsonMD, Gangnon RE, Klein BE. Changes in visual impairment prevalence by period of diagnosis of diabetes: theWisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology. 2009;116(10):1937- 1942.
6. Hovind P, Tarnow L, Rossing K, et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care. 2003;26(4): 1258-1264.
7. Klein R, KnudtsonMD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, XXII: the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008;115(11):1859-1868.
8. NordwallM, Bojestig M, Arnqvist HJ, Ludvigsson J; Linköping Diabetes Complications Study. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of type 1 diabetes: the Linköping Diabetes Complications Study. Diabetologia. 2004;47(7):1266-1272.
9. Klein R, KnudtsonMD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology. 2009;116(3):497-503.
10. National Institutes of Health National Eye Institute. From Vision Research to Health Education: Planning the Partnership. Bethesda, MD: National Institutes of Health National Eye Institute; 1990.
11. Hazin R, ColyerM, Lum F, Barazi MK. Revisiting Diabetes 2000: challenges in establishing nationwide diabetic retinopathy prevention programs. Am J Ophthalmol. 2011;152(5):723-729.
12. Chaturvedi N. The burden of diabetes and its complications: trends and implications for intervention. Diabetes Res Clin Pract. 2007;76(suppl 1):S3-S12.
13. Cugati S, Kifley A, Mitchell P, Wang JJ. Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: population-based survey findings. Diabetes Res Clin Pract. 2006;74(3):301-308.
14. Tsen KT, Morkoc H. Population relaxation time of nonequilibrium LO phonons and electron-phonon interactions in GaAs-AlxGa1-xAs multiple-quantum- well structures. Phys Rev B Condens Matter. 1986;34(6):4412-4414.
15. Centers for Disease Control and Prevention (CDC). Self-reported visual impairment among persons with diagnosed diabetes: United States, 1997-2010. MMWR Morb Mortal Wkly Rep. 2011;60(45):1549-1553.
16. Suh DC, Choi IS, Plauschinat C, Kwon J, Baron M. Impact of comorbid conditions and race/ethnicity on glycemic control among the US population with type 2 diabetes, 1988-1994 to 1999-2004. J Diabetes Complications. 2010;24(6):382-391.
17. Ong KL, Cheung BM, Wong LY, Wat NM, Tan KC, Lam KS. Prevalence, treatment, and control of diagnosed diabetes in the U. S. National Health and Nutrition Examination Survey 1999-2004. Ann Epidemiol. 2008;18(3):222-229.
18. Cheung BM, Ong KL, Cherny SS, Sham PC, Tso AW, Lam KS. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med. 2009;122(5):443-453.
19. Mann DM, WoodwardM, Ye F, Krousel-Wood M, Muntner P. Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors. Arch Intern Med. 2009;169(18):1718- 1720.
20. Zhang X, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304(6):649-656.
21. Klein BE, Klein R, Wang Q, Moss SE. Older-onset diabetes and lens opacities: the Beaver Dam Eye Study. Ophthalmic Epidemiol. 1995;2(1):49-55.
22. Klein BE, Klein R, Jensen SC. Open-angle glaucoma and older-onset diabetes: the Beaver Dam Eye Study. Ophthalmology. 1994;101(7):1173-1177.
23. Huffman MD, Capewell S, Ning H, Shay CM, Ford ES, Lloyd-Jones DM. Cardiovascular health behavior and health factor changes (1988-2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys. Circulation. 2012;125(21):2595-2602.
24. West SK, Lee P. Vision surveillance in the United States: has the time come? Am J Ophthalmol. 2012;154(6)(suppl):S1-S2; e1-e2.
25. Lee PP, West SK, Block SS, et al. Surveillance of disparities in vision and eye health in the United States: an expert panel's opinions. Am J Ophthalmol. 2012;154(6)(suppl):S3-S7.